Detalhe da pesquisa
1.
Differences in CD80 and CD86 transendocytosis reveal CD86 as a key target for CTLA-4 immune regulation.
Nat Immunol
; 23(9): 1365-1378, 2022 09.
Artigo
Inglês
| MEDLINE | ID: mdl-35999394
2.
Antibody agonists trigger immune receptor signaling through local exclusion of receptor-type protein tyrosine phosphatases.
Immunity
; 57(2): 256-270.e10, 2024 Feb 13.
Artigo
Inglês
| MEDLINE | ID: mdl-38354703
3.
Anti-CD3 treatment up-regulates programmed cell death protein-1 expression on activated effector T cells and severely impairs their inflammatory capacity.
Immunology
; 151(2): 248-260, 2017 06.
Artigo
Inglês
| MEDLINE | ID: mdl-28211040
4.
Combination CD200R/PD-1 blockade in a humanised mouse model.
Immunother Adv
; 3(1): ltad006, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37082107
5.
Immune Checkpoints as Therapeutic Targets in Autoimmunity.
Front Immunol
; 9: 2306, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-30349540
6.
Galectin-3 acts as an angiogenic switch to induce tumor angiogenesis via Jagged-1/Notch activation.
Oncotarget
; 8(30): 49484-49501, 2017 Jul 25.
Artigo
Inglês
| MEDLINE | ID: mdl-28533486